Literature DB >> 17385722

Puromycin insensitive leucyl-specific aminopeptidase (PILSAP) affects RhoA activation in endothelial cells.

Takahiro Suzuki1, Mayumi Abe, Hiroki Miyashita, Toshimitsu Kobayashi, Yasufumi Sato.   

Abstract

Puromycin insensitive leucyl-specific aminopeptidase (PILSAP) expressed in endothelial cells (ECs) plays an important role in angiogenesis due to its involvement in migration, proliferation and network formation. Here we examined the biological function of PILSAP with respect to EC morphogenesis and the related intracellular signaling for this process. When mouse endothelial MSS31 cells were cultured, a dominant negative PILSAP mutant converted cell shape to disk-like morphology, blocked stress fiber formation, and augmented membrane ruffling in random directions. These phenotypic changes led us to test whether PILSAP affected activities of Rho family small G-proteins. Abrogation of PILSAP enzymatic activity or its expression attenuated RhoA but not Rac1 activation during cell adhesion. This attenuation of RhoA activation was also evident when G-protein coupled receptors such as proteinase-activated receptor or lysophosphatidic acid receptor were activated in ECs. These results indicate that PILSAP affects RhoA activation and that influences the proper function of ECs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17385722     DOI: 10.1002/jcp.20980

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  2 in total

Review 1.  ERAP1 in the pathogenesis of ankylosing spondylitis.

Authors:  Emma Reeves; Tim Elliott; Edward James; Christopher J Edwards
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

Review 2.  Role of endoplasmic reticulum aminopeptidases in health and disease: from infection to cancer.

Authors:  Loredana Cifaldi; Paolo Romania; Silvia Lorenzi; Franco Locatelli; Doriana Fruci
Journal:  Int J Mol Sci       Date:  2012-07-04       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.